galactose. Analysis of the labelled gangliosides showed that in (i), (a) the labelling was mostly in the neuraminidase-labile sialyl groups, (b) rigid relationships exist between the enzymes and the sialyl acceptors; the enzymes are not free to interact with all the specific substrates present in the preparation and (c) the precursor ofthe trisialoganglioside was the major disialoganglioside with a sialyl 2-+8 sialyl group. In (ii), (a) precursor-product relationships between the main pools of each ganglioside apparently do not exist, (b) for the labelling of Tay-Sachs ganglioside the amount formed from hematoside was at least 2.5 times that from aminoglycolipid and (c) the major monosialoganglioside was the precursor for the major disialoganglioside with a sialyl 2--8 sialyl group.
[14C,]galactosamine or with CMP-N[3H]-acetylneuraminic acid and UDP-[U-14C]-
galactose. Analysis of the labelled gangliosides showed that in (i), (a) the labelling was mostly in the neuraminidase-labile sialyl groups, (b) rigid relationships exist between the enzymes and the sialyl acceptors; the enzymes are not free to interact with all the specific substrates present in the preparation and (c) the precursor ofthe trisialoganglioside was the major disialoganglioside with a sialyl 2-+8 sialyl group. In (ii), (a) precursor-product relationships between the main pools of each ganglioside apparently do not exist, (b) for the labelling of Tay-Sachs ganglioside the amount formed from hematoside was at least 2.5 times that from aminoglycolipid and (c) the major monosialoganglioside was the precursor for the major disialoganglioside with a sialyl 2--8 sialyl group.
The gangliosides are membrane constituents; however, very few membrane models have been proposed in which these compounds are considered (Lehninger, 1968) and we know of no report in which their synthesis is studied as part of a growing or turning-over membrane. A pathway for the biosynthesis of the carbohydrate chain of the gangliosides was proposed by Kaufman, Basu & Roseman (1966 ) and a different one by Kanfer, Blacklow, Warren & Brady (1964) , Yip & Dain (1969) and Handa & Burton (1969) . These pathways have been worked out from reactions occurring between water-soluble donors of glycosyl groups and lipid-soluble acceptors, catalysed by particulate preparations in a medium containing detergents which presumably altered the structures of the membranes. By using this method, possible steps for the synthesis are shown, but the natural relationships of the enzymes with their substrates are disregarded. The medium surrounding the membranes in vivo may convey the different substrates into contact with the enzymes as in the experiments with solubilized acceptors, but these also may be built attached to the membranes so that there are no interchanges with the pools of free intermediates. These different situations are important in determining the ratio of labelling of pools of metabolites related as precursor and product. If the precursor was obtained from a free pool, typical precursor-product relationship should be demonstrated; if the precursor was built and remained bound to the same particle that builds the product, non-typical relationship may be obtained. In the biosynthesis of neuraminyl-lactose, discrepancies between results of experiments in vitro and in vivo were explained because the synthesis obtained with free lactose, as carried out in vitro, is very small compared with the synthesis occurring when the synthesis of lactose and the binding of the sialyl group is carried out by the same enzyme complex (Barra, Cumar & Caputto, 1969) .
The present paper describes kinetic studies on the relationships between the enzymes and their endogenous substrates. It also deals with the incorporation of sialyl, galactosaminyl and galactosyl groups into endogenous acceptors of intact brain particles, to complete most of their different types of gangliosides. Distribution of labelling in endogenous Tay-Sachs ganglioside and multisialoganglioside in particles exposed to labelled donors in the supernatant are given. An important feature of the system used is that, similar to what occurs in vivo (Suzuki & Korey, 1964) , the pools of different gangliosides are built largely independently of each other; this probably reflects the similarity of conditions in which the acceptors are in vivo and in the particles. Another important observation in vivo, namely that in rats that had been given [1"C]glucose the neuraminidase-resistant sialyl group is more labelled than the neuraminidaselabile sialyl group (Suzuki & Korey, 1964 In cases where the distribution of radioactivity in different gangliosides was studied, larger amounts of particles were needed; better yield of particles was obtained when the brains were homogenized in 0.32M-sucrose and centrifuged at 10OOg for 10min, followed by the procedure described above but with 0.32M-sucrose in place of the tris-HCl-KCl solution. The particles were suspended in 0.32 M-sucrose-20 mM-potassium phosphate buffer, pH 6.8; the total volume was 1 ml/g of brain used as starting material.
The method of Eichberg, Whittaker & Dawson (1964) was followed for the preparation of subcellular organelles used to study the distribution of sialyltransferase.
Determination of 8ialyltransferaee activity. The incubation system contained, in a total volume of 0.5ml, 40,umol of potassium phosphate buffer, pH6.8; 5Ptmol of MgCl2; 10nmol of CMP-N['4C]-acetylneuraminic acid (sp. radioactivity, 9 x 106c.p.m./,tmol) and enzyme preparation equivalent to mg of protein. The incubation was carried out at 370C in test-tubes covered with waxed paper. To stop the reaction, 20 vol. of chloroformmethanol (2:1, v/v) was added and the mixture vigorously shaken; the mixture was filtered through paper and the filtrate was passed through a column containing 2 g of Sephadex G-25 equilibrated with chloroform-methanolwater (12:6:0.9, by vol.) by the method of Wells & Dittmer (1963 The dialysed upper phase was freeze-dried and the residue dissolved in approx. 10ml of chloroformmethanol-water (12:6:0.9, by vol.); any insoluble material was washed twice with the same solvent mixture and then eliminated by centrifugation. The soluble fractions were pooled and the freeze-drying and dissolving procedures repeated twice. The solution of the crude ganglioside mixture was passed through a Sephadex G-25 column (Wells & Dittmer, 1963) to eliminate any remaining non-lipid contaminants. The ganglioside mixture was subjected to t.l.c. on silica gel G (Merck) with chloroformmethanol-20% NH3 (60:35:8, by vol.) as solvent. To locate the various gangliosides a strip of about 2 cm was cut at the border of the plate and stained with the resorcinol reagent (Svennerholm, 1957) ; the rest of the plate was exposed to iodine vapour and the zones positive to both the resorcinol and iodine reagents were scrapped; six zones were separated each of which migrated to the same position as standard samples of respectively G Lac 1 (GM3)'* G GNTr 1 (GM2),
G GNT 2a (GDla), G GNT 2b (GDlb) and G GNT 3 (GTI). Penick, Meisler & McCluer (1966) found, with the solvent used, that G Lac 2 runs slightly below G GNT 1 (GM,), and G GNTr 2 between G GNT 2b (GD1b) and G GNT2a * Abbreviations: NANAc, N-acetylneuraminic acid. For gangliosides, the abbreviation system based on structural considerations tWiegandt, 1968) has been used.
The more commonly used nomenclature suggested by Svennerholm (1964) based on chromatographic mobility has been added in parentheses: hematoside G Lac 1 (GM3), (GDla) . The silica from the zones where G Lac 2 and G GNTr 2 were expected was not taken. The silica from each of the other zones was suspended in chloroformmethanol-water (10:10:3, by vol.) (Ledeen, Salsman & Cabrera, 1968) , placed in a column and washed with about 20vol. of the same solvent mixture. Each eluate was evaporated to dryness in a rotary evaporator at 35°C; the residuewas againsubjected to t.l.c., 3 itmol or less ofganglioside NANAc being placed on a plate (20 cm x 20cm; 0.27mm thick). In some cases some gangliosides were chromatographed three or four times before they appeared satisfactorily homogenous when sprayed with the resorcinol reagent. Authentic G GNTr 1 (GM2) was isolated from the brain of a patient with Tay-Sachs disease as follows. Total gangliosides were obtained as described above; the upper phase was made 0.15M with respect to KCI and partitioned twice with theoretical lower phase (Gatt, 1965) ; from the pooled lower phases G GNTr 1 (GM2) was purified by t.l.c.
Determination of the specific radioactivities of the neuraminidase-labile and resistant N[3H]-acetylneuraminic acid. Each of the fractions isolated as described above, corresponding to G Lac 1 (GM3), G GNTr 1 (GM2), G GNT 1 (GMI), G GNT 2a (GDla), G GNT 2b (GDlb) and G GNT 3 (GTI), was treated as follows: the total of G Lac 1 (GM3) and G GNTr 1 (GM2) obtained (about 0.1 and 0.05,umol respectively) and 0.3-1 temol of the major gangliosides were dried in test tubes; to each tube 66,umol of sodium acetate-acetic acid buffer, pH5.2, and 40,ug of Clostridium perfringens neuraminidase (Sigma, type VI) were added (Burton, 1963) . The total volume was 0.25ml. The mixtures were incubated for 3 h at 37°C. After incubation the mixtures were transferred to cellophan tubes and dialysed for a total of 12 h against three successive portions of 4ml of water. The diffusates containing the neuraminidase-labile N-acetylneuraminic acid were stored. To isolate the monosialogangliosides formed during the incubation with neuraminidase, the dialysis residues were run on t.l.c. under the same conditions as before. The amounts isolated showed that at least 90% ofmultisialogangliosides were converted into G GNT 1 (GM,) whereas the original G GNT 1 (GM,) was recovered unchanged; G GNTr 1 (GM2) was not run on t.l.c. buit passed through a Sephadex G-25 column (Wells & Dittmer, 1963) .
Each purified monosialoganglioside was hydrolysed for 2.5h at 80°C in 0.25ml of 0.05M-H2SO4. After this treament the neuraminidase-resistant NANAc was separated by dialysis. The fractions containing free NANAc were passed through columns (0.5 cmx 5cm) of, successively, Dowex 50 (H+ form) and Dowex 1 (formate form). After washing the columns with 30ml of water, NANAc was eluted from the Dowex-1 columns with m-formic acid; the formic acid was removed by freeze-drying and the residue was dissolved in water for NANAc determinations and radioactivity counting. All the radioactivity recovered from the columns migrated together with authentic NANAc in co-chromatography experiments. To determine the specific radioactivities of the different labile NANAc moieties of G GNT 3 (GT1), the observation of Svennerholm (1963) on their different susceptibility to neuraminidase was applied; G GNT 3 (GTI) was incubated with neuraminidase in the same conditions described above, but with a tenfold diluted enzyme preparation and for 15min only. The reaction was stopped by adding 4ml of chloroform-methanol (2:1, v/v); the solvent was evaporated and the residue was subjected to t.l.c.; the G GNT 2b (GD1b) obtained from G GNT 3 (GTI) was isolated from the plate and treated again with neuraminidase, by using the standard incubation system. The specific radioactivity of the NANAc bound to the terminal galactose was determined by the difference of specific radioactivities between total labile NANAc from G GNT 3 (GTI) and labile NANAc from their corresponding G GNT 2b (GDlb) .
Determinations of specific radioactivities of doublelabelled compounds. When a ganglioside was doubly labelled the specific radioactivities were determined directly on the intact compound isolated as described above. Preparation and purification of labelled CMP-Nacetylneuraminic acid and lactosylceramide. CMP-Nacetylneuraminic acid was prepared by the method of Roseman (1962) with the modification of Arce, Maccioni & Caputto (1966) ; CMP-N-acetylneuraminic acid was isolated free from NANAc, proteins and CTP by passing the preparation through a DEAE-cellulose column and eluting the CMP-N-acetylneuraminic acid with an increasing concentration of LiCl (Warren & Blacklow, 1962) . To eliminate LiCl, the dried eluate, containing approx. 3.5/,mol of CMP-N-acetylneuraminic acid, was taken up in the minimal amount of ethanol (15ml) and the salt suspension deposited on the top of a column (2.5 cmx 46 cm) of Whatman cellulose powder that had been washed with 0.1M-tris-acetate buffer, pH7.6, and then equilibrated with ethanol. The column was washed with ethanol until no more Cl-could be detected in the washing when it was tested with AgNO3 (approx. 600ml of ethanol was needed); after this, CMP-N-acetylneuraminic acid was eluted from the column with 0.2 mM-trisacetate buffer, pH 7.6; fractions (20ml) were collected and checked for radioactivity and extinction at 270nm. The fractions containing radioactivity and absorbing at 270nm were pooled and freeze-dried. Determination of free NANAc in the pool of nucleotide indicated that no more than 8-10% of the nucleotide was hydrolysed. The absorption spectrum was typical for cytidine and the cytidine/NANAc molar ratio was 1.23. Lactosylceramide was prepared as described by Cumar, Barra, Maccioni & Caputto (1968) .
Chemical determinations. Free sialic acid was determined by the method of Warren (1959) . In some cases the resorcinol reaction was used to determine bound NANAc; it was carried out by the method of Svennerholm as modified by Miettinen & Takki-Luukkainen (1959) . Protein was determined by the method of Lowry, Rosebrough, Farr & Randall (1951) ; bovine serum albumin was used as standard, unless indicated.
Measurement of radioactivity. Determinations of radioactivity were carried out in a Beckman model L-S 200 B liquid-scintillation spectrometer equipped with external standard. Determinations of radioactivity of double-labelled compounds were carried out by using the channel windows for counting 3H and '4C radioactivities separately. The samples were evaporated in vials, the residues dissolved in 0.1 ml of water and 5 ml of dioxan containing 10% of naphthalene and 0.5% of 2,5-diphenyloxazole was added. The error in the radioactivity counting was less than 5%; the efficiency was, for 3H, 30-35%, for Vol. 121 485 A. ARCE, H. J. MACCIONI AND R. CAPUTTO 14C, 92% as determined by external standardization, and for 14C above 3H, 58-62%.
RESULTS
Sialyltransferase activity of different 8ubcellular organelles. In a previous report ofthe distribution of sialyltransferase activity in different subcellular organelles, the crude mitochondrial fraction was used (Arce et al. 1966 ). Since the difference in the transferase activity between mitochondria and synaptosomes can be meaningful from the physiological point of view, an experiment was run to measure the activity in both fractions. The results showed ( Table 1 ) that the specific activity toward endogenous acceptors was about two-to three-fold higher in the mitochondria than in the other fractions whereas the specific activity with exogenous lactosylceramide as acceptor was somewhat higher in myelin than in the other fractions. In any case, the differences were small enough to justify the conclusion that the sialyltransferase activity is rather evenly distributed in all the subcellular particles.
Kinetic 8tudie8 with endogenou8 acceptor8. (a) Time curve of N[14C]-acetylneuraminic acid incorporation. Fig. 1 shows that the transference of NANAc from CMP-N-acetylneuraminic acid to acceptors attached to brain subcellular particles occurred at two distinct rates. During the initial period the velocity was relatively high, but at 8-lOmin an apparent inactivation occurred and the reaction proceeded, until the experiment was terminated, at a rate 5 times lower than in the initial period. Three causes may have possibly been responsible for this apparent inactivation, namely enzyme inactivation, destruction of CMP-N[14C]-acetylneuraminic acid or depletion of acceptors.
Enzyme inactivationi was discounted since the enzymic activity of particles preincubated for 15min at 370C in the absence of CMP-N[14C]-acetylneuraminic acid (but in otherwise identical conditions as in the incubation system) did not show any significant difference of activity with particles of the same batch maintained at 0-4°C. Destruction of CMP-N['4C]-acetylneuraminic acid was discounted because determination of NANAc by the method of Warren & Blacklow (1962) enzyme preparation equivalent to 0.5 mg of tyrosine. The incubation was carried out at 37°C for 1 h. For this experiment radioactivity was measured in a gas-flow counter. Particles were prepared by the method of Eichberg et al. (1964) . The values in the presence of added lactosylceramide (0.1,umol) for 15min approx. 2% of this compound was converted into N-acetylmannosamine; this was identified by paper chromatography with two different solvents and it was evaluated by radioactivity counting.
Since enzyme inactivation and CMP-N-acetylneuraminic acid destruction could be discounted as the causes of inactivation ofthe system, depletion of these acceptors or any other mechanism by which they become unaccessible remained as the most probable cause. Provided that this is correct, it was notable that the reaction followed a linear curve up to the breaking point (zero-order reaction) indicating that the enzyme was saturated with the endogenous acceptor at any concentration available. The nature of the substrate for the slow reaction of the final period has not been determined; this reaction probably was due to renewal of NANAc on the same gangliosides completed in the first period but it has not been excluded that it measured the transference of NANAc to a slow-reacting acceptor.
(b) Enzyme-concentration curve. In the transference of sialyl groups to endogenous acceptors of brain particles (Fig. 2 ) the plot of initial velocity versus enzyme concentration was linear; this showed that in our particulate system each particle was a compartment in the sense that the enzymes from one particle did not interact with the substrates of others. If this were not so the compound effect of a free enzyme and substrate system (Reiner, 1959) should have been observed.
(c) Heat-inactivation. Test tubes (0.5 cm diam.) containing particles obtained as stated in the Experimental section were immersed in a 520C bath for periods of from 15 to 70s; after these periods the tubes were immersed immediately in an ice-water bath where they were kept until used. The resulting preparations were tested by incubating for 6min in the presence of CMP-N[14C]-acetylneuraminic acid; results showed that the inactivation amounted to 13, 42 and 57% after 15, 45 and 70s in the 520C water bath, respectively. A preparation inactivated for 60s at 520C was compared with the original unheated preparation; it was found that the percentage of activity measured in the partially inactivated preparation relative to the original preparation was the same at 10, 20 and 60min of incubation with CMP-N-acetylneuraminic acid as donor and that the period at which the breaking point of the incorporation was reached was the same for the heated and the original preparations (Fig. 3) . Further, provided that the incorporation at lOmin measured the velocity of reaction whereas the incorporation at 60 min measured the total acceptor capacity of the preparation, it appeared that the decrease in the total amount ofNANAc incorporated into endogenous acceptors from heat-inactivated particulate enzyme preparation. *, Unheated control; o, heated at 5200 for 60s. Particulate preparation contained 0.5mg of protein/ml. Other assay conditions were as described in the Experimental section.
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(d) Effect ofexogenous acceptors on the incorporation of N-acetylneuraminic acid into endogenous acceptors. It is known that rat brain (Arce et al. 1966 ) and embryonic chicken brain (Kaufman et al. 1966 ) preparations catalyse the transference of NANAc from CMP-N-acetylneuraminic acid to lactosylceramide or lactose to form, respectively, hematoside or neuraminyl-lactose. In the present work it was investigated if in the presence of exogenous acceptors the incorporation of NANAc by the endogenous acceptors was inhibited. The specific radioactivity of each ganglioside after 5 and 15 min incubation was determined by the method of Suzuki & Chen (1967) . Addition oflactosylceramide (0.4mM) or lactose (16mM) had no effect on the rate ofincorporation ofNANAc to form the major mono-, di, or tri-sialogangliosides from endogenous acceptors. Conversely, attempts were made to elucidate whether the activity of the enzyme towards endogenous acceptors interfered with its activity towards exogenous lactosylceramide. (Arce, 1968) ; with endogenous acceptors and 1 mg of particulate enzyme preparation for an incubation period of 3 min, the Km value was 3 x 10-6 M. It is uncertain whether these Km values are comparable. In the determination of Km with exogenous acceptor this was at saturating concentration. For the reasons given above it was considered that the endogenous acceptors were saturating the enzyme, but in working with gangliosides in various stages of complexity, it is possible that different enzymes were competing for the donor CMP-N-acetylneuraminic acid, whereas only lactosylceramide was present as exogenous acceptor.
Distribution of labelled components incorporated into endogenous acceptors. it was synthesized from G GNT 1 (GM,) pre-existing in the particles. However, the specific radioactivity of the N-acetylgalactosamine (Table 3) or galactose (Table 5 ) moieties of G GNT 1 (GM1), G GNT 2a (GDla), G GNT 2b (GDlb) and G GNT 3 (GTI) indicate that the pools of these gangliosides are built independently between each other since no dilutions were observed in those moieties in passing from the pool of the monosialoganglioside to the pool of any of the disialogangliosides or from these to the trisialoganglioside.
(b) Pathway to Tay-Sachs ganglioside. The discrepancies in the pathway of synthesis of gangliosides apparent in experiments in vitro (see the introduction) appeared to be centred around the sequence of incorporation of the sialyl and galactosaminyl groups in G GNTr 1 (GM2); the double labelling of endogenous acceptors may contribute to solving this problem provided that a favourable combination of concentrations of the acceptors was found. After simultaneous incubation of the particles with UDP-N-acetyl[14C1]galactosamine and CMP-N[3H]-acetylneuraminic acid, the 14C/3H molar ratio in the Tay-Sachs ganglioside formed during the incubation period should be 1: 1, 1: 0 or 0:1, when the starting materials for its synthesis were lactosylceramide, hematoside or aminoglycolipid respectively. Results in Table 4 were calculated two ways since substantial amounts of sugar nucleotides were found in the particles and at present it is not known whether a part or all of the particle nucleotides interchange with the labelled nucleotides present in the incubation medium. Whether the incorporations were calculated assuming that only added nucleotides (14C/3H molar ratio 2.5: 1) or that all the recovered nucleotides were active donors in the system (14C/3H molar ratio 37.7:1), the molar ratios of incorporation of Nacetyl ['4C,] 
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Tay-Sachs ganglio8ide
The incubation system was as described in Table 3 . Tay-Sachs ganglioside was added as carrier to the inactivated incubation mixture; the ganglioside that migrated chromatographically as Tay-Sachs ganglioside was then isolated, treated with neuraminidase and purified to constant specific radioactivity as described in t The specific radioactivities of recovered nucleotides are indicated in Table 3 . 25ml; incubated at 3700 for 7min. The gangliosides were isolated, treated with neuraminidasa and purified as described in the Experimental section. Since no satisfactory constant radioactivities were obtained for sialyl groups of very low specific radioactivities in gangliosides in which sialyl groups with high specific radioactivities were present, no attempt has been made to compare these sialyl groups with other components of low specific radioactivities. Sp. activity (nmol incorporated/,umol of ganglioside) (GDlb) was obtained. In the experiment described in Table 6 , 33% of the theoretical amount of G GNT 2b (GDlb) was obtained; this was treated with neuraminidase under the standard conditions to release the labile NANAc attached through a 2->8 linkage to the resistant NANAc residue. The specific radioactivity of the released NANAc was determined (labile 2 8). the G GNT 3 (GT1) was synthesized from G GNT 2b (GDlb) .
DISCUSSION
The presence of sialyltransferases for gangliosides in all the subcellular organelles (Arce et al. 1966) indicated that each organelle synthesizes its own gangliosides; this was supported by experiments in vivo in which no sequential but simultaneous labelling of the gangliosides in different organelles was found (Rubiolo de Maccioni & Caputto, 1968; Harzer, Jatzkewitz & Sandhoff, 1969) . In addition, in the present work it was shown that rat brain particles are able to complete the formation of all the major gangliosides by using endogenous precursors attached to the particles and added watersoluble CMP-N-acetylneuraminic acid.
Some of the experiments in this work were devised to gain a first insight on the problem of the synthesis of gangliosides as membrane constituents. For this reason any treatment damaging the integrity of the particles, as, for instance, addition of detergents, was avoided, and so the system was expected to be essentially compartmentalized. That this was obtained was indicated by the linear curve of activity versus concentration of particles. This showed that the particles were active in discrete compartments; if interaction between substrates and enzymes from different particles had played an important part in the measured reactions, an exponential curve would have been obtained; any substrate from a given particle is in exogenous position to any enzyme from another particle, and there was no reason to assume that under the conditions of exogenous substrates they were at saturating concentrations all along the range of particle concentrations tested. In a system in which the largest possible compartments were the particles themselves, it was notable that the curve of activity versus time was that of a zero-order rather than a first-order reaction. On average, this means that in each particle the pools of acceptors are at saturating concentrations for the catalytic units in the same particle. But at the same time, the heat-inactivation experiments showed that activity and acceptor capacity of the preparations decreased simultaneously. One possible explanation is that a substrate is such for one enzyme or catalytic centre only and once this is inactivated the substrate cannot be used by another enzyme. We suggest that this observation fits well with those models ofmembrane in which enzymes and lipids are interdispersed in such a way that the lipids are distributed between the enzyme molecules (Sj6strand, 1968) In these models relatively small pools may be saturating the enzyme with which it is in almost continuous contact but once that particular enzyme is inactivated the substrate cannot get in contact with another enzyme.
From the specific radioactivity of common moieties of gangliosides (such as N-acetylgalactosamine and galactose), no indications were found of precursor-product relationships between the monoand di-sialogangliosides or between these and the trisialoganglioside, since there was no definite radioactive dilution between them. This does not necessarily mean that in building up a complex ganglioside it does not pass through the stages of less complex compounds of the same group; but evidently, provided that this is the mechanism of synthesis, only a small part of each pool is formed of stages in the formation of the more complex compounds. Whether the different stages travel on the surface of the corresponding enzymes or the acceptor is in a set position and in it the total compound is built up, there is no way of deciding at present. Our attempts to demonstrate reciprocal interference between endogenous and exogenous acceptors on the incorporation of NANAc failed; because of the uncertainties as to the conditions of the endogenous substrate no definite conclusion can be drawn from these experiments but they indicate that the enzymes working with acceptors in these two positions are different.
The rigid arrangement suggested by our findings provides an explanation for the independent biosynthesis of each of the different gangliosides found by Suzuki & Korey (1964) Abbreviation: Cer, ceramide (2-N-acylsphingosine).
Very little of the major gangliosides was synthesized by starting at the lactosylceramide stage even in the experiments in which the particles were incubated with CMP-N-acetylneuraminic acid and UDPgalactose simultaneously. Since determinations of UDP-N-acetylgalactosamine in the particles showed that this was at a higher concentration than total (endogenous plus added) CMP-N-acetylneuraminic acid, the lack of nucleotides was not the explanation for the failure to synthesize mono-, di-, and tri-sialogangliosides from lactosylceramide. This again suggests that the membrane is in a rigid arrangement and that the endogenous nucleotides are not free to reach every possible reacting position; alternatively the requirements of the position and not the presence of donors and acceptors determines whether the synthesis will proceed further. Another possibility is that sialidase-resistant NANAc was incorporated but passed undetected because it was transferred from an unlabelled precursor, which, because of its position or its chemical nature, is better able to act as donor than the CMP-Nacetylneuraminic acid in the supernatant. The complete understanding of the synthesis of gangliosides will have to wait for the clarification of these points; in the meantime the present experiments with endogenous acceptors provide some information on pathways occurring with donors present in the fluid surrounding the membranes. Probably, this is a further step towards solving the problem of the synthesis in vivo since the experiments involved more physiological conditions than exist when donors and acceptors are added from outside. The pathways proposed for G Lac 1 (GM3) by Arce et al. (1966) and by Kaufman et al. (1966) and for G GNT 2a (GD1a) by Kaufman et al. (1968) are in agreement with the labelling of the endogenous acceptors. To study the pathway for G GNTr 1 (GM2) and G GNT 2b (GDlb) double labelling was needed; the interpretation of the experiment in which G GNTr 1 (GM2) was labelled with N-[3H]-acetylneuraminic acid and N-acetyl[14C1]galactosamine indicated that 2.5 times as much G GNTr 1 (GM2) was formed from hematoside as from G GNTr.
If the N-acetylgalactosamine/NANAc incorporation ratio is calculated from the specific radioactivities of recovered nucleotides the difference increases but it is not certain whether all or part of the endogenous nucleotides present in the particle intervenes as a donor.
Simultaneous labelling with N[3H]-acetylneuraminic acid and N-acetyl ['4Cl]galactosamine showed that in this system the labelling of G GNT 2b (GDlb) through the pathway G GNTr 1 (GM2) --> G GNT 2b (GDlb) is at least 400 times higher than the pathway G Lac 2 --> G GNT 2b (GDlb) predicted from structural considerations by Kaufman et al. (1968) and by Wiegandt (1968) . Simultaneous labelling with N[3H]-acetylneuraminic acid and [U-14C]galactose showed that the pathway was G GNTr 1 (GM2) G GNT 1 (GM1) -+ G GNT 2b (GDlb) .
In connection with the synthesis of G GNT 3 (GTO1)
the results of endogenous incorporation of NANAc showed that the precursor is G GNT 2b (GDlb) since the sialyl group found labelled after incubation of the particles with CMP-N[3H]-acetylneuraminic acid was that bound to the galactose at the non-reducing end. Kaufman et al. (1968) and Wiegandt (1968) suggested this pathway for the synthesis of G GNT 3 (GT1) but as far as we know the first experimental evidence for it is the one described in the present work. The pathway for the synthesis of the G GNT 2a (GDla), G GNT 2b (GD1b) and G GNT 3 (GT1) suggested by the incorporation of labelled components to endogenous acceptors is depicted in Scheme 1. 
